Logo image of ARK.CA

ARRAS MINERALS CORP (ARK.CA) Stock Fundamental Analysis

TSX-V:ARK - TSX Venture Exchange - CA04271V1058 - Common Stock - Currency: CAD

1  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ARK. ARK was compared to 797 industry peers in the Metals & Mining industry. ARK has a bad profitability rating. Also its financial health evaluation is rather negative. ARK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ARK has reported negative net income.
ARK had a negative operating cash flow in the past year.
ARK.CA Yearly Net Income VS EBIT VS OCF VS FCFARK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

ARK's Return On Assets of -61.21% is on the low side compared to the rest of the industry. ARK is outperformed by 67.00% of its industry peers.
ARK has a Return On Equity of -92.90%. This is in the lower half of the industry: ARK underperforms 65.12% of its industry peers.
Industry RankSector Rank
ROA -61.21%
ROE -92.9%
ROIC N/A
ROA(3y)-68.29%
ROA(5y)N/A
ROE(3y)-78.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARK.CA Yearly ROA, ROE, ROICARK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARK.CA Yearly Profit, Operating, Gross MarginsARK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for ARK has been increased compared to 1 year ago.
Compared to 1 year ago, ARK has an improved debt to assets ratio.
ARK.CA Yearly Shares OutstandingARK.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
ARK.CA Yearly Total Debt VS Total AssetsARK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

ARK has an Altman-Z score of 16.42. This indicates that ARK is financially healthy and has little risk of bankruptcy at the moment.
ARK has a better Altman-Z score (16.42) than 77.42% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that ARK is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.00, ARK perfoms like the industry average, outperforming 52.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.42
ROIC/WACCN/A
WACCN/A
ARK.CA Yearly LT Debt VS Equity VS FCFARK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

ARK has a Current Ratio of 0.66. This is a bad value and indicates that ARK is not financially healthy enough and could expect problems in meeting its short term obligations.
ARK has a worse Current ratio (0.66) than 64.99% of its industry peers.
A Quick Ratio of 0.66 indicates that ARK may have some problems paying its short term obligations.
ARK has a worse Quick ratio (0.66) than 62.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
ARK.CA Yearly Current Assets VS Current LiabilitesARK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

ARK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.26%, which is quite good.
EPS 1Y (TTM)8.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1016%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARK.CA Price Earnings VS Forward Price EarningsARK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARK.CA Per share dataARK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ARK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARRAS MINERALS CORP

TSX-V:ARK (8/8/2025, 7:00:00 PM)

1

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.27%
Inst Owner ChangeN/A
Ins Owners4.38%
Ins Owner ChangeN/A
Market Cap120.35M
AnalystsN/A
Price Target1.12 (12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 18.34
P/tB 18.34
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.21%
ROE -92.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-68.29%
ROA(5y)N/A
ROE(3y)-78.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 16.42
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)26.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1016%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.62%
OCF growth 3YN/A
OCF growth 5YN/A